350 related articles for article (PubMed ID: 6275986)
21. [Effects of a combination chemotherapy "VEMA" consisting of vincristine, cyclophosphamide, methotrexate and ACNU in the treatment of small cell bronchogenic carcinoma].
Kojima T; Ito Y; Nakanishi F; Sugihara T; Nagata K; Kamiya O; Ohara K; Hoshino A
Gan To Kagaku Ryoho; 1983 Jun; 10(6):1491-6. PubMed ID: 6307169
[TBL] [Abstract][Full Text] [Related]
22. [Small cell lung carcinoma: role of thoracic irradiation and its timing in relation to chemotherapy].
Payne DG; Murray N; Warde P
Bull Cancer; 1994 Feb; 81(2):119-28. PubMed ID: 7894117
[TBL] [Abstract][Full Text] [Related]
23. A randomized study of radiation treatment in small cell bronchial carcinoma treated with two types of four-drug chemotherapy regimens.
Nõu E; Brodin O; Bergh J
Cancer; 1988 Sep; 62(6):1079-90. PubMed ID: 2457422
[TBL] [Abstract][Full Text] [Related]
24. Cyclophosphamide, doxorubicin, and cisplatin in the treatment of non-small cell bronchogenic carcinoma.
Evans WK; Feld R; DeBoer G; Osoba D; Curtis JE; Baker MA; Myers RE; Quirt IC; Pritchard KI; Brown TC; Kutas GJ; Blackstein ME; Ottema B; Millband L
Cancer Treat Rep; 1981; 65(11-12):947-54. PubMed ID: 7028256
[TBL] [Abstract][Full Text] [Related]
25. Cyclophosphamide, adriamycin, methotrexate, and procarbazine (CAMP)--effective four-drug combination chemotherapy for metastatic non-oat cell bronchogenic carcinoma.
Bitran JD; Desser RK; DeMeester TR; Colman M; Evans R; Billings A; Griem M; Rubenstein L; Shapiro C; Golomb HM
Cancer Treat Rep; 1976 Sep; 60(9):1225-30. PubMed ID: 189920
[TBL] [Abstract][Full Text] [Related]
26. [Combination treatment of small cell bronchial carcinoma].
Voss AC; Steinke B; Ostendorf P; Teller P; Gnann H
Strahlentherapie; 1983 Jan; 159(1):18-21. PubMed ID: 6301108
[TBL] [Abstract][Full Text] [Related]
27. Superior vena caval obstruction due to small-cell anaplastic lung carcinoma. Response to chemotherapy.
Kane RC; Cohen MH
JAMA; 1976 Apr; 235(16):1717-8. PubMed ID: 176480
[TBL] [Abstract][Full Text] [Related]
28. [Small-cell anaplastic bronchopulmonary cancers. Prognostic and therapeutic review apropos 49 cases].
Lebeau B; Ameille J; Leclerc P; Turhan A; Rochemaure J
Ann Med Interne (Paris); 1983; 134(2):95-8. PubMed ID: 6192744
[TBL] [Abstract][Full Text] [Related]
29. Lack of efficacy of high-dose methotrexate by 30-hour infusion in patients with progressive small cell carcinoma of the lung.
Ihde DC; Johnston-Early A; Carney DN; Cohen MH; Bunn PA; Pelsor FR; Minna JD
Cancer Treat Rep; 1982 May; 66(5):1223-5. PubMed ID: 6282453
[TBL] [Abstract][Full Text] [Related]
30. Combination chemotherapy in metastatic or recurrent non-small cell bronchogenic carcinoma. 5-year results.
Ojala A; Nikkanen VN; Paloheimo S; Palojoki A; Thölix E
Strahlentherapie; 1983 Dec; 159(12):775-7. PubMed ID: 6364459
[TBL] [Abstract][Full Text] [Related]
31. Pilot study with weekly chemotherapy for patients with extensive small cell lung cancer: an Eastern Cooperative Oncology Group Study (PA586).
Yuen AR; Fuks JZ; Ettinger DS; Chang AY; Ruckdeschel JC; Phan SC; Blum RH
Cancer J Sci Am; 2000; 6(1):34-9. PubMed ID: 10696737
[TBL] [Abstract][Full Text] [Related]
32. Bleomycin, methotrexate, and CCNU in locally advanced or recurrent, inoperable, squamous-cell carcinoma of the vulva: an EORTC Gynaecological Cancer Cooperative Group Study. European Organization for Research and Treatment of Cancer.
Wagenaar HC; Colombo N; Vergote I; Hoctin-Boes G; Zanetta G; Pecorelli S; Lacave AJ; van Hoesel Q; Cervantes A; Bolis G; Namer M; Lhommé C; Guastalla JP; Nooij MA; Poveda A; Scotto di Palumbo V; Vermorken JB
Gynecol Oncol; 2001 Jun; 81(3):348-54. PubMed ID: 11371121
[TBL] [Abstract][Full Text] [Related]
33. Long term survivors after resection of bronchial carcinoma.
Shields TW; Robinette CD
Surg Gynecol Obstet; 1973 May; 136(5):759-62. PubMed ID: 4349729
[No Abstract] [Full Text] [Related]
34. Cisplatin combination chemotherapy in non-oat cell carcinoma of the lung.
Vincent RG; Lane WW; Raza S; Madajewicz S
Cancer Treat Rep; 1982 Jan; 66(1):197-8. PubMed ID: 6975658
[No Abstract] [Full Text] [Related]
35. [Prognostic factors in the chemotherapy of bronchial cancers].
Alberto P
Schweiz Med Wochenschr; 1974 Feb; 104(8):268-71. PubMed ID: 4360755
[No Abstract] [Full Text] [Related]
36. Bleomycin (NSC-125066) followed by cyclophosphamide (NSC-26271), vincristine (NSC-67574), methotrexate (NSC-740), and 5-fllorouracil (NSC-19893) for non-oat cell bronchogenic carcinoma.
Lanzotti VJ; Thomas DR; Holoye PY; Boyle LE; Smith TL; Samuels ML
Cancer Treat Rep; 1976 Jan; 60(1):61-8. PubMed ID: 63331
[TBL] [Abstract][Full Text] [Related]
37. Concurrent cisplatin-etoposide chemotherapy plus thoracic radiotherapy for limited-stage small cell lung cancer. Japanese Lung Cancer Chemotherapy Group in Japanese Clinical Oncology Group.
Ariyoshi Y; Fukuoka M; Furuse K; Saijo N; Ikegami H; Nishiwaki Y; Tamura T; Shimoyama M; Suemasu K
Jpn J Clin Oncol; 1994 Oct; 24(5):275-81. PubMed ID: 7967106
[TBL] [Abstract][Full Text] [Related]
38. [MACC plus thymostimulin (TP-1 Serono) therapy of small cell bronchogenic carcinoma. Clinico-immunologic evaluation of the results of a randomized trial].
Salvati F; Pallotta G; Antilli A; Nunziati F; De Marinis F; Lucchesi M
G Ital Chemioter; 1984; 31(1-2):185-9. PubMed ID: 6088341
[No Abstract] [Full Text] [Related]
39. Etoposide (VP-16) containing combination chemotherapy for treatment of patients with small cell lung cancer.
Behera D; Jindal SK; Sharma SC
Indian J Chest Dis Allied Sci; 1995; 37(1):15-9. PubMed ID: 16892733
[TBL] [Abstract][Full Text] [Related]
40. "CAMP" combination chemotherapy for unresectable non-oat cell bronchogenic carcinoma.
Lad T; Sarma PR; Diekamp U; Tichler T; Chawla M; Krauss S; Zawila P; Nelson R
Cancer Clin Trials; 1979; 2(4):321-6. PubMed ID: 394868
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
